Oncternal Therapeutics (ONCT) Free Cash Flow (2019 - 2024)
Oncternal Therapeutics (ONCT) free cash flow from Jun 30, 2019 to Sep 30, 2024. The TTM Oncternal Therapeutics (ONCT) free cash flow is -$27M. You can adjust inflation or export chart.
Annual Free Cash Flow
Quarterly Free Cash Flow
Oncternal Therapeutics (ONCT) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -23.34% |
| 3 Years TTM | +3.70% |
| 5 Years TTM | +21.47% |
| All Time TTM | +14.22% |
Annual Free Cash Flow change of Oncternal Therapeutics (ONCT)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2024 | -$20M | -37.16% |
| 2023 | -$32M | -12.37% |
| 2022 | -$37M | +38.02% |
| 2021 | -$27M | +51.94% |
| 2020 | -$18M | +4.48% |
| 2019 | -$17M | N/A |